Pimicotinib

• 和誉-B午后涨超4% Pimicotinib获FDA授予快速通道认定2023-12-20
• 和誉-B：CSF-1R抑制剂Pimicotinib (ABSK021)获FDA快速通道认定2023-12-14
• 和誉-B(02256)附属和誉医药与Merck就Pimicotinib(ABSK021)达成授权合约2023-12-04
• 和誉-B(02256)：Pimicotinib (ABSK021)治疗晚期胰腺癌II期临床试验完成国内首例患者给药2023-11-28